603566.SHG Pulike Biological Engineering

Healthcare Pharmaceuticals Shanghai Stock Exchange
9.32 CNY
Close of Nov 4, 2026
9.00 14.58
Market cap
CNY 3.23B
P/E
30.1x
P/B
1.27x
ROE
4.2%
Dividend yield
6.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603566.SHG undervalued?

Graham number
Price9.32
Graham value7.17
Premium30.0%

603566.SHG trades 30.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pulike Biological Engineering fundamental analysis

No fundamental analysis for Pulike Biological Engineering yet.

Pulike Biological Engineering stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pulike Biological Engineering

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for livestock, poultry, and pets. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.

Full company profile